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Background/Purpose: Acute myocardial infarction (AMI) results in more complications and increased
mortality in octogenarians compared to patients in younger age groups. This study investigated the short-
and long-term outcomes in octogenarians after primary percutaneous coronary intervention (PCI).
Methods: During the study period from May 1997 to August 2004, 54 patients * 80 years old with ST-elevation
myocardial infarction (STEMI) were eligible for primary PCI. Data collected included baseline clinical
characteristics and usage of cardiovascular medications. Diagnostic coronary angiography and revascularization
procedures were performed using standard practices. During hospitalization, the clinical course including
serial changes in cardiac enzymes, adverse events associated with myocardial infarction or treatment, and
inhospital or long-term mortality of patients were recorded.
Results: The mean age of the 54 patients (35 men, 19 women) was 82.8 ± 2.5 years (range, 80–89 years).
Among them, 27 (50%) had anterior infarction, six (11%) had anterolateral infarction, and 21 (39%) had
inferior infarction, inclusive of three patients with accompanying right ventricular infarction. Among them,
20 (37%) patients were in Killip class I, nine (17%) were in class II, two (4%) in class III, and 23 (43%) in
class IV. The mean delay from onset of symptoms to arrival in hospital was 220 ± 167 minutes, and 189 ±
169 minutes from hospital arrival to reperfusion. Diagnostic coronary angiography revealed that 48 (89%)
patients had multivessel disease. Inhospital death occurred in 23 (43%) patients, with the leading causes of
death being profound cardiogenic shock (61%), and free wall rupture (26%).
Conclusion: Octogenarian patients who developed STEMI tended to have multivessel disease. These patients
had a high inhospital mortality rate that was most likely to be due to cardiogenic shock. [J Formos Med Assoc
2006;105(6):451–458]
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There is a high prevalence of coronary artery dis-
ease in octogenarians (* 80 years old),1 and they
are also the fastest growing segment of the popu-
lation. In the United States, over 50% of acute
myocardial infarctions (AMIs) occur in people
older than 65 years, and 80% of those who die
from AMI are more than 65 years old.2 A popula-
tion-based study conducted between 1975 and
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1995 found that patients aged 75–84 and * 85
years had 7.8 and 10.2 times greater risk of dying
from AMI during hospitalization than patients
younger than 55 years.3 Age is a strong independ-
ent predictor of outcomes, including inhospital
and post-hospital mortality rates, in patients with
AMI4,5 because of its association with increased
severity of coronary atherosclerosis, reduced car-
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having three-vessel disease if it was dominant.
Multivessel disease was defined as * 50% diame-
ter stenosis in two or more major epicardial coro-
nary arteries. The flow of the infarct-related artery
(IRA) was categorized from grade 0 to grade 3 ac-
cording to the Thrombolysis In Myocardial Infarc-
tion (TIMI) grading system. After diagnostic coro-
nary angiography, the revascularization procedure
was tailored to the individual patient and selected
solely by the physicians. However, the family could
choose conservative treatment if emergency coro-
nary artery bypass graft (CABG) was suggested.
Procedural success was defined as a reduction to
residual stenosis of < 40% by balloon angioplasty
or successful stent deployment at the desired posi-
tion with a residual stenosis < 20% followed by
TIMI grade 2 or 3 flow in the IRA.
Concomitant medical therapy
All patients were treated with aspirin 300 mg oral-
ly as the loading dosage and then 100 mg daily.
Unfractionated heparin 5000 IU was given intra-
venously before the procedure, and then infused
continuously for 48 hours. Ticlopidine 250 mg
twice a day or clopidogrel 300 mg loading dose,
followed by 75 mg per day was administered after
stent placement for at least 1 month.
Data collection, follow-up and study endpoint
Detailed inhospital and follow-up data were col-
lected, including serum creatine level, white blood
cell (WBC) count, Killip score on hospital admis-
sion, reperfusion time, peak cardiac enzyme level
and its timing, and inhospital adverse events such
as sepsis, atrial or ventricular arrhythmia, and MI-
related cardiac rupture or acute mitral regurgita-
tion documented by echocardiography. Cardio-
genic shock was defined as sustained hypotension
with systolic blood pressure < 80 mmHg unrespon-
sive to intravenous fluids, requiring vasopressors
or intra-aortic balloon pump. Major bleeding
was defined as significant blood loss from any site
not caused by trauma and requiring transfusion.
Left ventricular ejection fraction (LVEF) was meas-
ured after primary PCI or before discharge by the
area–length method using a Sonos 4500 or 5500
diac reserve and multiple comorbidities.6,7 Early
reperfusion via primary percutaneous coronary
intervention (PCI) or thrombolytic therapy is the
cornerstone of effective treatment for patients with
ST-elevation myocardial infarction (STEMI).8 How-
ever, there are many limitations to thrombolytic
therapy in the older population, and some studies
have suggested that primary PCI is superior to
thrombolytic therapy and leads to a lower rate
of hemorrhagic stroke9 and greater reduction in
the rates of mortality and reinfarction.10,11
There are limited data on the efficacy and safe-
ty of primary angioplasty in octogenarians. This
study analyzed the short-term and long-term out-
comes, including disease severity, complications,
inhospital and follow-up mortality rates, in 54
octogenarian patients with STEMI who received
primary PCI at National Taiwan University Hospi-
tal (NTUH) between May 1997 and August 2004.
Methods
Patients
All octogenarian patients identified from the
NTUH catheterization laboratory database who
met the eligibility criteria were included. Patients
had acute STEMI, defined as at least 30 minutes
but < 12 hours of symptoms, and the presence of
ST-segment elevation * 1 mm in at least two con-
tiguous leads or presumed new bundle-branch
block on the presenting 12-lead electrocardiogram.
Right ventricular infarction was diagnosed based
on the finding of ST-elevation in lead V4R. Patients
who had suspected STEMI but couldn’t be referred
for urgent coronary angiography due to prolonged
resuscitation or any other causes were excluded.
Coronary angiography and primary angioplasty
After obtaining informed consent, coronary angio-
graphy was performed initially via the femoral
artery according to standard clinical practice. Dis-
eased coronary artery was defined as * 50% dia-
meter stenosis, and the left main coronary artery
was classified as having two-vessel disease if the
left coronary artery was non-dominant, and as
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(Hewlett-Packard, Palo Alto, CA, USA) with a 2–4
MHz transducer. The duration of hospital stay and
causes of inhospital death were recorded. Clinical
features such as baseline serum creatine, WBC
count, Killip class, peak cardiac enzyme level and
its timing, LVEF, and free wall rupture were ana-
lyzed for their association with mortality. Other
data analyzed included congestive heart failure,
defined based on the New York Heart Association
classification, target lesion or target vessel revas-
cularization (TLR/TVR), and post-hospital mortal-
ity at follow-up.
Statistical analysis
All values were expressed as mean ± standard
deviation. Comparisons between parametric vari-
ables were performed using unpaired Student’s t
test, while comparisons between categorical vari-
ables were performed using the chi-square test
with Yates’ correction if needed. The survival rate
after the episode of STEMI was plotted using the
Kaplan-Meier method. All analyses were performed
with SPSS version 10.0 (SPSS Inc, Chicago, IL, USA)
and the Statistical Analysis System (SAS Institute
Inc, Cary, NC, USA).
Results
A total of 54 octogenarian patients who met
the eligibility criteria were identified from the
NTUH catheterization laboratory database. The
baseline characteristics of the patients are summa-
rized in Table 1. There were 35 males and 19 fe-
males with a mean age of 82.8 ± 2.5 years (range,
80–89 years). About 80% of patients had hyper-
tension, but less than half had a history of dia-
betes mellitus (37%), hyperlipidemia (24%),
smoking (26%), or stroke (7%). Among the 54 pa-
tients, 9% had prior myocardial infarction (MI),
7% had previously received PCI, and only 2% had
received CABG. Before the AMI episode, less than
one fourth of patients used cardiovascular medi-
cations such as aspirin, `-blockers, angiotensin
converting enzyme inhibitors/angiotensin II re-
ceptor blockers, antiarrhythmic drugs, digitalis,
diuretics, calcium channel blockers, nitrates, or
lipid-lowering agents.
Clinical and procedural features
Among the 54 patients, 30 (56%) experienced
preinfarction angina, and the others presented
with other symptoms such as shortness of breath
or syncope. The clinical features and procedural
data of the patients are summarized in Table 2.
The delay from onset of symptoms to examination
in the emergency room was 220 ± 167 minutes.
The infarct site was in the anterior wall in 27 (50%)
patients, anterolateral wall in six (11%), and
inferior wall in 21 (39%). Of the 21 patients with
inferior MI, three (14%) had right ventricular in-
farction. Initial presentation was Killip class I
(free of rales and a third heart sound) in 20 (37%)
patients, Killip class II (rales < 50% of lung fields
Table 1. Baseline characteristics of the 54
octogenarian patients with ST-
elevation myocardial infarction
n (%)
Sex (Male/Female) 35/19
Mean age ± SD (yr) 82.8 ± 2.5
Hypertension 42 (78)
Diabetes mellitus 20 (37)
Smoking 14 (26)
Hyperlipidemia 13 (24)
Prior MI 5 (9)
Prior CHF 10 (19)
Prior CVA 4 (7)
Prior PCI 4 (7)
Prior CABG 1 (2)
Aspirin 12 (22)
`-blocker 07 (13)
ACEI/ARB 08 (15)
Antiarrhythmic drugs 07 (13)
Digitalis 3 (6)
Diuretics 07 (13)
Calcium channel blockers 07 (13)
Nitrates 06 (11)
Lipid-lowering agents 1 (2)
ACEI/ARB = angiotensin converting enzyme inhibitor/angiotensin
II receptor blocker; CABG = coronary artery bypass graft; CHF =
congestive heart failure; CVA = cerebrovascular accident; MI =
myocardial infarction; PCI = percutaneous coronary intervention;
SD = standard deviation.
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and with or without a third heart sound) in nine
(17%), Killip class 3 (rales > 50% of each lung
field) in two (4%), and Killip class IV (cardiogenic
shock) in 23 (43%). One patient with sudden car-
diac death had MI diagnosed by 12-lead electro-
cardiography after resuscitation. Multivessel dis-
ease was diagnosed by coronary angiography in
48 (89%) patients. The pre-PCI stenosis of the IRA
was 97 ± 7%. TIMI flow before intervention was
grade 0 in 28 (52%) patients, grade 1 in 11 (20%),
grade 2 in 12 (22%), and grade 3 in three (6%).
PCI was performed in 43 (80%) patients. A total
of 29 stents were implanted. Successful results
were achieved in 41 (95%) patients, with a reper-
fusion time of 407 ± 226 minutes after the onset
of symptoms, and a final residual stenosis of 5 ±
9%. In the two patients with failed PCI, the
guidewire could not cross the stenotic lesion in
one patient who was then treated conservatively,
and the no-reflow phenomenon developed in the
other patient who received CABG soon thereafter.
Of the 11 patients who did not receive PCI, five
underwent primary CABG, and the other six were
treated conservatively at their family’s request due
to refractory ventricular tachycardia (VT)/ventri-
cular fibrillation (VF), old age, or other comorbid
conditions associated with expected poor prog-
nosis. Creatinine kinase peaked 14.2 ± 7.3 hours
after the onset of symptoms, with a mean value
of 4654 ± 4336 U/L in patients with successful
PCI, and at 27.0 ± 10 hours with a mean value of
6386 ± 9191 U/L in patients with failed PCI.
Inhospital course and follow-up prognosis
The inhospital course and follow-up data are sum-
marized in Table 3. During hospitalization, intra-
aortic balloon counterpulsation was used for
hemodynamic stability in 22 (41%) patients with
cardiogenic shock. The measured LVEF of these
patients was 43.3 ± 16.5%. Paroxysmal atrial fi-
brillation and VT/VF occurred in six (11%) and 12
(22%) patients, respectively. Two (4%) patients
developed severe bleeding complications, which
presented as intracranial and subarachnoid hem-
orrhage in one, and as massive upper gastrointes-
tinal bleeding with hypovolemic shock needing
Table 2. Clinical features and procedural data
of the 54 octogenarian patients with
ST-elevation myocardial infarction*
Preinfarction angina 30 (56)
Arrival time (min) 220 ± 167
Reperfusion time (min) 407 ± 226
Initial WBC (1/μL) 10,630 ± 46180.
Creatinine (mg/dL) 1.5 ± 1.1
Killip class
I 20 (37)
II 09 (17)
III 2 (4)
IV 23 (43)
IRA
LM 1 (2)
LAD 26 (48)
LCX 06 (11)
RCA 21 (39)
RV infarction 03 (14)
Pre-PCI TIMI flow
Grade 0 28 (52)
Grade 1 11 (20)
Grade 2 12 (22)
Grade 3 3 (6)
Multivessel disease 48 (89)
Pre-PCI stenosis (%) 97 ± 7
Total PCI 43 (80)
Stenting 29 (67)
Successful PCI 41 (95)
Residual stenosis (%) 5 ± 9
Post-PCI TIMI flow
Grade 2 3 (7)
Grade 3 38 (93)
Peak CK (U/L) 4654 ± 4336
Peaking time (hr) 14.2 ± 7.30
Failed PCI 2 (5)
CABG 06 (11)
Conservative treatment 07 (13)
*Data are presented as n (%) or mean ± standard deviation.
CABG = coronary artery bypass graft; CK = creatinine kinase;
IRA = infarct-related artery; LAD = left anterior descending artery;
LCX = left circumflex artery; LM = left main coronary artery;
PCI = percutaneous coronary intervention; RCA = right coronary
artery; RV = right ventricular; TIMI = Thrombolysis In Myocardial
Infarction; WBC = white blood cell.
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transarterial embolization of the left gastric artery
in the other. Both patients were discharged smooth-
ly at 37 days and 7 days, respectively, after the
MI episode. Inhospital death occurred in 23 (43%)
patients, including in all of those who received
conservative management and in 16 of the 47 pa-
tients (34%) who underwent successful aggres-
sive treatment. At presentation, non-survivors had
significantly (p < 0.05) higher Killip class (3.2 ±
1.2 vs. 2.0 ± 1.2), creatinine (1.9 ± 1.6 vs. 1.1 ± 0.3
mg/dL) and peak creatinine kinase (7012 ± 7455
vs. 3340 ± 2909 U/L), longer time until peaking
cardiac enzyme (19.6 ± 10.5 vs. 14.2 ± 7.3 hours),
lower LVEF (36 ± 12 vs. 49 ± 17%), and more free
wall rupture (26 vs. 0%) than survivors until
discharge. The mean hospital stay of non-survivors
was 17 ± 44 days, and most of them (17 patients,
74%) died within 7 days after MI. The leading
causes of inhospital death were profound left
ventricular failure with cardiogenic shock (61%),
free wall rupture with cardiac tamponade (26%),
refractory VT/VF (4%), pneumonia with septic
shock (4%), and acute mitral regurgitation with
pulmonary edema and respiratory failure (4%). The
31 (57%) patients who were discharged smoothly
had a mean hospital stay of 20 ± 22 days, and suf-
fered from symptoms of congestive heart failure
with mean New York Heart Association class 2.2 ±
0.6. At a mean of 30.1 ± 22.5 months of follow-
up, eight (26%) patients had received revasculari-
zation at a mean of 7.8 ± 7.2 months after the
initial treatment, including one patient with recur-
rent symptoms after CABG, and seven patients with
TLR/TVR, among whom three patients did not re-
ceive stent implantation during the primary PCI
procedure. Of the five patients who died during
follow-up, cardiovascular events were considered
to be the cause of death in two, including acute
lung edema resulting in respiratory failure at 68
days in one, and sudden cardiac death at 1 year
post-discharge in the other. Another three patients
died of non-cardiovascular causes, including pneu-
monia with septic shock at 3 months in one, ische-
mic bowel disease presenting as acute abdomen at
11 months in one, and gastric cancer at 1 year post-
discharge in one.
Kaplan-Meier curve for analysis of survival rate
The Kaplan-Meier curve of the overall survival of
the 54 octogenarians with STEMI eligible for pri-
mary PCI is shown in the Figure. Inhospital mor-
tality (n = 23, 43%) was responsible for most of
the initial decline in survival within 2 months of
the AMI episode. Another five patients among the
31 survivors who were discharged died within 1
year.
Table 3. Inhospital and follow-up course in
54 octogenarian patients with ST-
elevation myocardial infarction*
VT/VF 12 (22)
PAF 06 (11)
CAVB 11 (20)
IABP 22 (41)
LV ejection fraction (%) 43.3 ± 16.5
Severe bleeding 2 (4)
Major bleeding 01 (50)
Intracranial hemorrhage 01 (50)
Inhospital deaths 23 (43)
Mean hospital stay (d) 17 ± 44
Causes of death
Profound cardiogenic shock 14 (61)
Free wall rupture 06 (26)
Refractory VT/VF 1 (4)
Septic shock 1 (4)
Acute mitral regurgitation 1 (4)
Survived to discharge 31 (57)
Mean hospital stay (d) 20 ± 22
NYHA class 2.2 ± 0.6
Revascularization 08 (26)
Mean time of revascularization (mo) 7.8 ± 7.2
Target vessel revascularization 07 (88)
Follow-up mortality 05 (16)
Causes of death
Cardiovascular 02 (40)
Septic shock 01 (20)
Acute abdomen 01 (20)
Gastric cancer 01 (20)
*Data are presented as n (%) or mean ± standard deviation.
CAVB = complete atrioventricular block; IABP = intra-aortic
balloon pump; LV = left ventricular; NYHA = New York Heart
Association; PAF = paroxysmal atrial fibrillation; VT/VF =
ventricular tachycardia/ventricular fibrillation.
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Discussion
Primary angioplasty is increasingly advocated as
an approach that should supersede thrombolysis
for the treatment of acute STEMI,12,13 especially in
the elderly.14,15 Although risks to octogenarians
undergoing PCI are two- to fourfold higher than
in younger patients,16 a randomized trial by De
Boer et al also disclosed that primary angioplasty,
compared with intravenous streptokinase treat-
ment, reduced the 30-day composite incidence of
death, reinfarction or stroke from 29% to 9% in
patients > 75 years of age.17
In this study, nearly half (43%) of octogenari-
ans with acute STEMI initially presented with car-
diogenic shock, a substantially higher percentage
than the average of 7–10% reported in the general
population18,19 in studies from the United States.
Only eight (35%) of these patients survived to
discharge, with an inhospital mortality rate of 65%
even after revascularization, which is lower than
the previously reported 30-day mortality rates in
the United States of 44% in patients aged * 75
years20 and 70% in those aged * 80 years in Italy.15
As a part of the aging process, coronary arteries are
prone to dilation, tortuosity, medial calcification
and impairment of endothelial function,21 in ad-
dition to reduced cardiac and overall physiologic
reserve. All of these factors may contribute to the
high incidence of multivessel (89%) or complicat-
ed coronary artery disease resulting in increased
difficulty22,23 of angioplasty in octogenarians. In
this series, coronary intervention was considered
inappropriate after diagnostic angiography in
20% of patients. There was also a high prevalence
(43%) of cardiogenic shock in octogenarian pa-
tients with AMI.
Although the high success rate (95%) of pri-
mary coronary intervention in this study was sim-
ilar to previous studies,15 the mean hospital stay
was still prolonged and the inhospital mortality
rate (43%) was much higher than previously re-
ported. The main causes of inhospital death were
profound left ventricular failure with cardiogenic
shock (61%) and free wall rupture (26%). Aged
hearts are more prone to ischemic injury because
of impaired ischemic preconditioning24 and de-
creased angiographic presence of collaterals to the
IRA.25 Delay in time to reperfusion may result in
impaired myocardial perfusion and greater in-
jury,25 which contribute to poor inhospital prog-
nosis in this population. Therefore, cardiogenic
shock, free wall rupture, and life-threatening ar-
rhythmias are more likely to occur in elderly pa-
tients26 and lead to a worse short-term progno-
sis.27,28
Among the 31 survivors who received reper-
fusion therapy (CABG, n = 2) and were discharged,
five (16%) patients died within 1 year due to car-
diovascular events or other non-cardiac etiology.
This is consistent with the findings of Singh et al
that the long-term prognosis following success-
ful angioplasty was similar to that of the general
population.29 Revascularization was needed in
eight (26%) of these patients at a mean of 7.8 ±
7.2 months. The Controlled Abciximab and De-
vice Investigation to Lower Late Angioplasty Com-
plications (CADILLAC) trial found that coronary
stenting reduced the 1-year rate of ischemic target
revascularization (7.0% vs. 17.6%; p < 0.001) com-
pared with balloon angioplasty alone among eld-
erly (* 65 years) patients.30 The older population
and the 67% stent implantation rate in this study
might explain the higher rates of revascularization
in comparison to the CADILLAC study.
Although elderly patients are at higher risk of
stroke and major bleeding than younger patients,
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Figure. Kaplan-Meier survival estimates of 54 octogenarian patients with ST-elevation
myocardial infarction (STEMI).
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the incidence (4%) of severe bleeding was accept-
able in this study of octogenarian patients who re-
ceived primary angioplasty when compared to the
0–8% rate reported previously in the elderly.31,32
Study limitations
The major limitation of this study was the lack of
a control group, which would have been difficult
to form because the absolute patient number was
small even when collected over a relatively long
study period, and other standard aggressive treat-
ment such as thrombolytic therapy was rarely
indicated. Thus, the results and findings must be
interpreted as descriptive as opposed to demon-
strating effectiveness. This study supports, how-
ever, that this age group benefits from primary
angioplasty for AMI. Another limitation was the
inclusion only of patients in the catheterization
laboratory database. The inclusion of some patients
with STEMI and sudden cardiac death or death on
arrival might have caused a major selection bias
leading to underestimation of the frequency of ad-
verse outcomes. Nevertheless, the patients includ-
ed in this study represented a high-risk population,
and the data are likely to be representative of out-
comes in this high-volume catheterization labora-
tory with experienced operators.
Conclusion
In the era of primary angioplasty, octogenarians
with acute STEMI still have a high probability of
complex coronary stenoses, worse initial presen-
tation, prolonged hospital stay, and higher overall
mortality. Whether newer pharmacotherapy such
as antiplatelet agents, device therapy such as em-
bolic protecting filters or thrombectomy catheters,
or drug-eluting stents can improve the prognosis
of this population warrants further investigation.
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